INSIGHTS ON CLINICAL TRIAL PARTNERING

CLINICAL TRIAL PARTNERING SOLUTIONS

  • With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.

  • Navigating drug safety in the era of innovation-driven medicine

    The focus on drug safety and pharmacovigilance has never been more intense. Patient safety remains paramount throughout a product's lifecycle, even as sponsors and marketing authorization holders (MAHs) face increasing complexity in managing safety data. This complexity stems from huge volumes of data generated from scores of diverse sources, much of it rapidly expanding unstructured data. Innovation-driven medicine is a key factor. These dynamics are reshaping the landscape of drug safety, presenting both challenges and opportunities for innovation in pharmacovigilance practices.

  • Expert ophthalmic teams rescue clinical trials with stabilized studies, nationwide coverage, and eye assessments, helping protect endpoints and regain timeline control quickly.

  • Our approach is designed to optimize efficiency and accelerate timelines, resulting in up to 40% time savings throughout the early phases of your drug development journey.

  • With this single, purpose-built platform, uncover how sponsors can deliver greater quality, oversight, and efficiency throughout the entire imaging lifecycle.